lactic acid has been researched along with Central Nervous System Cysticercosis in 2 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The debut study was aimed to develop Lactic acid (LA)-conjugated solid lipid nanoparticles (SLN-LA) bearing albendazole (ALB) and prednisolone (PRD) for effective management of neurocysticercosis (NCC)." | 7.81 | Dual Drug Delivery Using Lactic Acid Conjugated SLN for Effective Management of Neurocysticercosis. ( Devi, R; Hurkat, P; Jain, A; Jain, SK, 2015) |
| "Nitazoxanide (NTZ) is an antifolate containing the pyrrolopyrimidine-based nucleus that exerts its antiprotozoal activity due to interference with the pyruvate:ferredoxin oxidoreductase (PFOR) enzyme which is essential to anaerobic energy metabolism." | 5.51 | Oral nitazoxanide treatment of experimental neurocysticercosis induces gluconeogenesis in Taenia crassiceps cysticerci. ( Alves, DSMM; Costa, TL; Isac, E; Lima, NF; Lino Junior, RS; Picanço, GA; Silva, LD; Vinaud, MC, 2019) |
| "The debut study was aimed to develop Lactic acid (LA)-conjugated solid lipid nanoparticles (SLN-LA) bearing albendazole (ALB) and prednisolone (PRD) for effective management of neurocysticercosis (NCC)." | 3.81 | Dual Drug Delivery Using Lactic Acid Conjugated SLN for Effective Management of Neurocysticercosis. ( Devi, R; Hurkat, P; Jain, A; Jain, SK, 2015) |
| "Nitazoxanide (NTZ) is an antifolate containing the pyrrolopyrimidine-based nucleus that exerts its antiprotozoal activity due to interference with the pyruvate:ferredoxin oxidoreductase (PFOR) enzyme which is essential to anaerobic energy metabolism." | 1.51 | Oral nitazoxanide treatment of experimental neurocysticercosis induces gluconeogenesis in Taenia crassiceps cysticerci. ( Alves, DSMM; Costa, TL; Isac, E; Lima, NF; Lino Junior, RS; Picanço, GA; Silva, LD; Vinaud, MC, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lima, NF | 1 |
| Picanço, GA | 1 |
| Alves, DSMM | 1 |
| Silva, LD | 1 |
| Isac, E | 1 |
| Costa, TL | 1 |
| Lino Junior, RS | 1 |
| Vinaud, MC | 1 |
| Devi, R | 1 |
| Jain, A | 1 |
| Hurkat, P | 1 |
| Jain, SK | 1 |
2 other studies available for lactic acid and Central Nervous System Cysticercosis
| Article | Year |
|---|---|
Oral nitazoxanide treatment of experimental neurocysticercosis induces gluconeogenesis in Taenia crassiceps cysticerci.
Topics: Administration, Oral; Animals; Anthelmintics; Chromatography, High Pressure Liquid; Cysticercus; Ene | 2019 |
Dual Drug Delivery Using Lactic Acid Conjugated SLN for Effective Management of Neurocysticercosis.
Topics: Animals; Drug Carriers; Drug Delivery Systems; Humans; Kinetics; Lactic Acid; Lipids; Nanoparticles; | 2015 |